between bacterial biofilm and the epithelium, degranulate MMP-8 (collagenase-2 or neutrophilic collagenase), being of major importance in etiopathogenesis of periodontal disease (Alfakry, Malle, Koyani, Pussinen, & Sorsa, 2016) . In periodontitis, MMP-8 is the major collagenase in periodontal tissues and over 90% of the collagenase activity in gingival crevicular fluid (GCF), saliva and mouthrinse originates from MMP-8 . While MMP-8 is one of the most important degradative enzymes in pathogenesis of periodontal disease at pathologically elevated levels, its total absence disrupts host-defensive response, which associates with progression of periodontitis and systemic inflammation, as demonstrated in a MMP-8 knockout-mice model (Kuula et al., 2009) . Elevated levels of activated MMP-8 in oral fluids have been proposed as diagnostic markers of periodontitis (Ebersole, Nagarajan, Akers, & Miller, 2015; Gürsoy, Pussinen, Salomaa, Syrjäläinen, & Könönen, 2018; Gursoy et al., 2010; Sorsa et al., 2016) .
By using immunodetection methods, MMP-8 can be found in several molecular forms in GCF and peri-implant sulcus fluid; these include complexes at sizes of >110 kDa, latent (pro) and active forms of neutrophilic MMP-8 at 70-80 kDa, mesenchymal-type collagenase at 50-65 kDa with latent (pro) and active forms and fragments at 20-30 kDa Hasty, Hibbs, Kang, & Mainardi, 1986; Kiili et al., 2002; Palosaari et al., 2000; Reynaud af Geijersstam, Sorsa, Stackelberg, Tervahartiala, & Haapasalo, 2005) . It has been shown that Treponema denticola, a major periodontitis-associated bacterium, can activate proMMP-2 with its chymotrypsin-like protease (Miao, Fenno, Timm, Joo, & Kapila, 2011) . Active neutrophilic 55 kDa MMP-8 is considered one major form in periodontitis (Romanelli et al., 1999; Sorsa et al., 2010) . Detecting high levels of active MMP-8 in saliva has a strong diagnostic ability in comparison to methods that detect total MMP-8 levels (Gursoy et al., 2010) . Although molecular forms of MMP-8 have been demonstrated in GCF and peri-implant sulcus fluid (Kiili et al., 2002; Kivelä-Rajamäki et al., 2003; Sorsa et al., 2010) , to our knowledge, relationships of different molecular forms of salivary MMP-8 fractions to periodontitis have not been studied yet.
Moreover, the activation of proMMP-8 by T. denticola chymotrypsinlike protease (Td-CTLP) has not been demonstrated before. According to our hypothesis, in periodontitis, secreted MMP-8 is subjected to auto-or bacterial degradation, and MMP-8 fragments become detectable as early diagnostic markers of active disease and disease severity. With this background, the aim was to examine the molecular forms of MMP-8 in saliva and the degree of activation and fragmentation of MMP-8 in relation to periodontitis.
| MATERIAL AND ME THODS
2.1 | Activation of human recombinant proMMP-8 by Td-CTLP, sodium hypochlorite (NaOCl) and Amino Phenyl Mercuric Acetate (APMA)
Purified PMN MMP-8 was prepared as described by Hanemaaijer et al. (1997) . Human proMMP-8 (20 μg) was treated with Td-CTLP, as described by Sorsa et al. (1992) , 1 mM NaOCl (Pharmacy of University of Helsinki, Helsinki, Finland), and 1 mM APMA (Sigma, St Luis, MO, USA), and the activations were monitored by westernimmunoblotting (Ding et al., 1996; Saari, Suomalainen, Lindy, Konttinen, & Sorsa, 1990 ).
| Saliva samples
The paraffin-stimulated saliva samples came from participants of the Southern Finland district of the national Finnish Health 2000 survey (BRIF8901), and the clinical data from oral and radiographic examinations of the survey participants are described in the report of the National Public Health Institute (http://www.terveys2000.fi/indexe. html). All participants gave written informed consent, and study pro- Digital panoramic radiographs were used to determine the alveolar bone loss (Gursoy et al., 2013) . Radiographs were taken with a dental panoramic X-ray machine (imaging values between 58-68 kV for 5 min, and the supernatants were used for the biochemical assays.
A total of 223 saliva samples, collected from 81 subjects with generalized periodontitis (GP) (14 or more teeth with ≥4 mm probing pocket depth [PPD] ), 63 subjects with localized periodontitis (LP with two subgroups; LP1: 2 teeth with PPD of ≥4 mm, and LP2: 7 teeth with PPD of ≥4 mm) and 79 subjects without pocket teeth (control), were included in the present study. Mean bone loss levels were 33.3 ± 41.4 mm for GP, 11.1 ± 12.5 mm for LP1, 18.3 ± 26.2 for LP2 and 3.5 ± 5.4 mm for the control group (Gursoy et al., 2013) . All patients in the GP and LP groups showed bone loss, and the patient was used as the unit of analysis. All Health 2000 survey subjects who fit into above-mentioned groups were included in the study. (40-60) years for the control group. Percentages of smokers were 56.6% for GP, 25.0% for LP1, 34.5% for LP2 and 23.5% for the control group. Male percentage was 60.2% for the GP, 41.7% for LP1, 41.4% for LP2 and 35.8% for the control group.
| Immunoblotting of salivary MMP-8
All samples were analysed together, and the laboratory staff was unaware of the study groups in which the samples belong to. For detecting the molecular forms of salivary MMP-8, a modified method of the enhanced chemiluminescence (ECL) Western immunoblotting kit (GE Healthcare, Amersham, UK) was used according to the protocol recommended by the manufacturer (Hanemaaijer et al., 1997; Lauhio et al., 1994) . Briefly, 14 μl of saliva were mixed with Laemmli's buffer without the reducing reagent and heated for 5 min, and protein separations were performed with 11% sodium dodecyl sulphate (SDS)-polyacrylamide gels. After electrophoresis, the proteins were electrotransferred onto nitrocellulose membranes (Protran, Whatman GmbH, Dassel, Germany), which were incubated overnight with a primary polyclonal antibody, anti-MMP-8 (Hanemaaijer et al., 1997; Lauhio et al., 1994) . Target detection was performed according to the manufacturer's protocol. The quantitation of immunoblots was performed by using the GS-700 Imaging Densitometer
Scanner and the Bio-Rad Quantity One program (Bio-Rad, Hercules, CA, USA).
| Detection of Treponema denticola
Salivary T. denticola levels were available for the control and GP groups from our previous study (Hyvärinen et al., 2009 ). The analysis of T. denticola was performed using a single copy gene-based real-time PCR (Hyvärinen et al., 2009) . The results are expressed as concentrations using genomes per millilitre (GE/ml). To define the predictive capabilities of each molecular form of MMP-8 present in saliva, salivary levels of MMP-8 forms were first divided into tertiles and then the participants were grouped according their tertile scores. Number of teeth with deepened pockets (PPD ≥ 6 mm) in 2011 was taken as outcome variable.
| Follow-up study

F I G U R E 1
In vitro activation and fragmentation of human proMMP-8 by Td-CTLP, NaOCl and APMA. The 85 kDa human recombinant proMMP-8 was incubated with Treponema denticola chymotrypsin-like protease (Td-CTLP) for indicated time periods (a), oxidant 1 mM NaOCl (b) and organomercurial 1 mM APMA (c), and these activations and related fragmentations were monitored by western-immunoblotting. Treponemal protease, oxidant NaOCL and organomercurial APMA time-dependently activated and fragmented human proMMP-8 (a-c)
| Statistical analyses
All statistical analyses were performed with the SPSS statistical program (version 23.0; IBM Armonk, New York, USA). The data distributions of MMP-8 fraction levels were skewed; therefore, non-parametric tests were applied. The Kruskal-Wallis H (for multiple comparisons) and Mann-Whitney U tests were used for comparing the levels of the molecular forms of MMP-8 between the four periodontal groups. The Spearman test was used to analyse the correlations between different forms of MMP-8 and salivary T. denticola levels. A statistical significance was defined as a p-value <0.05.
| RE SULTS
Purified MMP-8 was in part autofragmented and self-activated.
Human 70-80 kDa proMMP-8 was converted to its 50-60 kDa active forms by tested Td-CTLP, HOCl, and APMA and further induced to the fragmented lower molecular size of 20-27 kDa fragments (Figure 1a-c) .
The molecular forms, activations and fragments of salivary MMP-8 are given in Figure 2 . The relative levels of MMP-8 complexes at >110 kDa were higher in LP2 group than in controls (p = 0.032). No difference was observed in pro-forms of neutrophilic MMP-8. The active form of neutrophilic MMP-8 was lowest in LP1 group, in comparison to the control (p = 0.033) and GP F I G U R E 2 Western-immunoblot analysis of salivary samples studied for molecular forms, degree of activation and related fragmentation of MMP-8. Lanes 1-2: control -; lanes 3-4: LP1; lanes 5-6: LP2; lanes 7-8: GP. Lane 9 indicates neutrophilic (PMN) proMMP-8 (pMMP-8), active PMN MMP-8 (aMMP-8) and fragments (frag.) F I G U R E 3 Salivary levels of molecular forms and fragments of MMP-8 in subjects with generalized periodontitis [14 or more teeth with ≥4 mm probing pocket depth (PPD)], localized periodontitis (LP1: 2 teeth with ≥4 mm PPD and LP2: 7 teeth with ≥4 mm PPD) and in subjects without pocket teeth (control). Significant differences between the groups were given as connecter lines and p-values Salivary levels of T. denticola were 1.64 × 10 4 GE/ml for the GP group and 5.64 × 10 3 GE/ml for the controls. There were significant correlations between fragments of MMP-8 and T. denticola 
| D ISCUSS I ON
In the present study, we demonstrated that MMP-8 present in saliva can be observed in complex, active and pro neutrophilic and active and pro mesenchymal forms, as well as in low molecular weight (20-27 kDa) fragments. Among these molecular forms, the fragments of salivary MMP-8 were elevated in both localized (early) and generalized (advanced) forms of periodontitis. 
Control vs. LP2
This is the first study to characterize the molecular forms and fragmentation of salivary MMP-8 in periodontitis. A previous study, dealing with molecular forms and levels of MMP-8 in GCF, demonstrated increases in active forms of neutrophilic and mesenchymal MMP-8 during periodontitis, whereas fragments of MMP-8 were barely detectable (Kiili et al., 2002) . In another study, using periimplantitis sulcus fluid, all six forms of MMP-8 were found at higher levels in peri-implant mucositis and peri-implantitis cases in comparison to those in healthy controls (Kivelä-Rajamäki et al., 2003) . The salivary profile of MMP-8 in periodontitis seems to differ, at least partly, from its profile in GCF during periodontitis and in peri-implant sulcular fluid during peri-implantitis.
Neutrophilic MMP-8 is secreted, or degranulated, as a 75 kDa molecule in pro-form and is reduced to its active form at 57 kDa (Hasty et al., 1986) . The 20-27 kDa fragments of MMP-8 are degradation end-products of 57 kDa neutrophilic MMP-8 activation and are without collagenase activity (Hasty et al., 1986) . Release, activation and fragmentation of MMP-8 upon degranulation from neutrophils is regulated by bacteria (Reynaud af Geijersstam et al., 2005) , especially by periodontitis-associated pathogens (Ding et al., 1996 . Bacterial enzymes convert pro neutrophilic MMP-8 to its active form and matrilysin-1 (MMP-7) is responsible for its proteolytical cleavage (Dozier, Escobar, & Lindsey, 2006; Sorsa et al., 1992) . MMP-8 can also be activated by oxidative mechanisms without having a reduction in its molecular weight (Saari et al., 1990 ).
MMP-8 fragments, on the other hand, are end-products of autoand bacterial degradation of degranulated 57 kDa MMP-8 (Hasty et al., 1986; Reynaud af Geijersstam et al., 2005) . The degradation of 57 kDa MMP-8 by T. denticola was demonstrated in this study as well. Moreover, salivary levels of fragmented MMP-8 correlated significantly with salivary T. denticola concentrations. In the present study, only low levels of active neutrophilic MMP-8 were found in saliva of LP1 group in comparison to the generalized periodontitis and control groups. This might be explained by the bacterial degradation of MMP-8 in initial periodontitis (here: in subjects with two pocket teeth). The released MMP-8, which is at low levels during initial periodontitis, can be subjected to bacterial proteases and get degraded (Nieminen et al., 2017; Sorsa et al., 1992) . Active neutrophilic MMP-8 levels of LP2 and GP groups were higher than those of LP1, but at the same time similar to that of controls. This outcome might be explained by the simultaneous elevations of neutrophilic MMP-8 and bacterial proteases with the extension of the disease. In the present study, the gradual extension of periodontal disease from localized to generalized disease leads to consistently increased levels of low molecular size (20-27 kDa) fragments of MMP-8 and the ROC curve analysis results supported this statement. Our findings on salivary MMP-8 fragments suggest that their levels increase with the progression of periodontitis and stay at elevated levels during extension of the disease. Indeed, it seems that full-size pro-form MMP-8 is ready for a potential activation and fragmentation upon periodontal disease initiation and progression, and the occurrence of elevated levels of MMP-8 fragments is an outcome of this extended MMP-8 activation. In fact, corresponding MMP-8 activation and fragmentation cascades have been described during neutrophilic degranulation in vitro (Hasty et al., 1986; Reynaud af Geijersstam et al., 2005) and in vivo in other body fluids and secretions, such as diabetic nephropathic urine, glaucoma-affected tear fluid and bronchiectasisaffected bronchoalveolar lavage (Lauhio et al., 2008; Määttä, Tervahartiala, Vesti, Airaksinen, & Sorsa, 2006; Prikk et al., 2002) .
The most common methods to detect MMP-8 in body fluids are the enzyme-linked immunosorbent assay and time-resolved immunofluorometric assay (IFMA). These two methods measure total MMP-8 levels, or latent and active forms of MMP-8, alone or together (Sorsa, Gieselmann, Arweiler, & Hernández, 2017; Sorsa et al., 2016) .
The only method to analyse molecular forms and/or fragments of MMP-8 is the computer-scanned western-immunoblots (Buduneli et al., 2011; Kiili et al., 2002) . The computer-quantitated westernimmunoblots and IFMA have been demonstrated to correlate significantly with each other, indicating that both immunotechniques are suitable for oral fluid MMP-8 analyses (Buduneli et al., 2011) . The ROC curve analysis obtained by computer-scanned immunoblots provided AUC scores of >0.7 for 20-27 kDa salivary MMP-8 fragments, which corresponds to those previously obtained by MMP-8 IFMA analysis (Gursoy et al., 2010; Mauramo et al., 2017) .
In the present study, no clear differences were found in the levels of pro and active forms of mesenchymal MMP-8 between the control and periodontitis groups. The main source of mesenchymal MMP-8 in saliva is fibroblasts, but other cells (odontoblasts) can secrete this MMP-8 isoform as well (Palosaari et al., 2000) . (Scott & Krauss, 2012) , bacterial lipopolysaccharide induces apoptosis of fibroblasts (Alikhani et al., 2003) . Increase in apoptotic behaviour of fibroblasts may explain why fibroblastic (mesenchymal) MMP-8 did not differ between the periodontal groups in our study. Furthermore, upon activation, this isoform of MMP-8 can be fragmented into low molecular weight fragments (Hanemaaijer et al., 1997) .
Based on the present findings, generalized periodontitis patients with elevated fragmented forms of salivary MMP-8 have deepened probing pocket depths after 10 years. To our knowledge, this is one of the first studies to demonstrate the predictive capability of salivary biomarkers in a longitudinal design over 10 years.
In conclusion, fragments of MMP-8 resulting from its activation become detectable in saliva at initial phases of periodontitis and can be considered a possible biomarker of periodontitis. 
